Following the cessation of the activities of Genizon Biosciences Inc. in September 2011, the Superior Court of Qu\u00e9bec mandated G\u00e9nome Qu\u00e9bec to take charge of the management of data and biological samples collected. The biological material (50,000 samples including 200,000 tubes) was relocated at the BioBank of G\u00e9nome Qu\u00e9bec – Centre Hospitalier Affili\u00e9 Universitaire in Chicoutimi.<\/p>\n
Databases have been repatriated to the premises operated by G\u00e9nome Qu\u00e9bec. As trustee of the Genizon Biosciences Inc. data and samples, G\u00e9nome Qu\u00e9bec has ensured that the integrity of the biobank was preserved and subsequent research activities will be conducted in accordance with the established governance framework.<\/p>\n
\u00a0<\/p>\n
After analysis and consultation with various groups of experts, G\u00e9nome Qu\u00e9bec is launching a Call for Tenders for the transfer of Genizon Biosciences assets to a Qu\u00e9bec research center while respecting the wishes expressed by the participants and the applicable ethical standards. Bids will be submitted to a review process by national (outside Quebec) and international experts. This process will be managed by the Fonds de recherche du Qu\u00e9bec – sant\u00e9 (FRQS). The result of the evaluations provided by FRQS will be handed over to Genome Qu\u00e9bec and the selected research center will be announced at the end of March 2013. The selected research center should provide the anonymized data and material of the biobank to the Quebec scientific community.<\/p>\n
\u00a0<\/p>\n
G\u00e9nome Qu\u00e9bec is a not-for-profit organization which funds major genomics research initiatives and their application. It receives funding from the Government of Qu\u00e9bec, Genome Canada and other sources. If you are interested in responding to this Call for Tenders, please send a letter of intent to G\u00e9nome Qu\u00e9bec for instructions on the invitation to tender before January 11, 2013.<\/p>\n","protected":false},"excerpt":{"rendered":"
Following the cessation of the activities of Genizon Biosciences Inc. in September 2011, the Superior Court of Qu\u00e9bec mandated G\u00e9nome Qu\u00e9bec to take charge of the management of data and…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[294],"tags":[],"class_list":["post-16525","post","type-post","status-publish","format-standard","hentry","category-nouvelles"],"acf":[],"_links":{"self":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts\/16525","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/comments?post=16525"}],"version-history":[{"count":0,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts\/16525\/revisions"}],"wp:attachment":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/media?parent=16525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/categories?post=16525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/tags?post=16525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}